Clinical Research Division, Fred Hutchinson Cancer Research Center — Seattle, Washington

Clinical Research Division, Fred Hutchinson Cancer Research Center is a clinical research site located in Seattle, Washington, United States 98109.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Clinical Research Division, Fred Hutchinson Cancer Research Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Research Division, Fred Hutchinson Cancer Research Center?

Clinical Research Division, Fred Hutchinson Cancer Research Center has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Research Division, Fred Hutchinson Cancer Research Center conducted?

Clinical Research Division, Fred Hutchinson Cancer Research Center has 1 clinical trials on record, with 1 currently active. Their work covers Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis.

Is Clinical Research Division, Fred Hutchinson Cancer Research Center accredited by Crixeo Health?

Clinical Research Division, Fred Hutchinson Cancer Research Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Research Division, Fred Hutchinson Cancer Research Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.